Molecular Characterization of Neuroendocrine-like Bladder Cancer

Abstract

A single-patient classifier was developed that identifies patients with histologic urothelial cancer harboring a NE transcriptomic profile. These tumors represent a high-risk subgroup of MIBC, which may require different treatment.